NASDAQ: BNGO performance in March fell from $1.25 to $0.46 when investors were reluctant to buy any share because of the COVID-19 lockdown. Fortunately, since April 8 the stock has been growing slowly by giving a nice chance to short-term traders in making quite a serious margin. The rapid growth started on May 21 and kept soaring until this week’s Friday.
On the 18th of June Bionano Genomics will report its Q1 2020 earnings. It seems its management is not in a rush to unveil its overall quarter performance. Perhaps, the stock might jump after the report goes online. If Q1 earnings are not promising BNGO may lose significant value.